Re­lo­cat­ing its US HQ to Boston, French phar­ma Ipsen to add 250 jobs

Boston’s biotech hub has at­tract­ed yet an­oth­er HQ, as French phar­ma com­pa­ny Ipsen said Thurs­day it will re­lo­cate its US op­er­a­tions from New Jer­sey to Kendall Square.

The com­pa­ny an­nounced the move on the last day of the BIO In­ter­na­tion­al Con­ven­tion, promis­ing to add 250 new jobs with the ex­pan­sion of its Boston pres­ence. Ipsen, which has a $11.2 bil­lion mar­ket cap, al­ready opened two out­posts in the city back in 2015: a com­mer­cial/man­u­fac­tur­ing site at One Kendall Square and an R&D site at 650 East Kendall St. Now, it’s mov­ing all 150 of its Boston em­ploy­ees in­to the East Kendall lo­ca­tion.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.